Exactech, Inc. EXAC, a developer and producer of bone and joint
restoration products for hip, knee, shoulder, spine and biologic materials,
announced today that the Deferred Prosecution Agreement entered into
effective December 7, 2010 with the United States Attorney's Office for the
District of New Jersey (USAO) has expired. The Company satisfied its
obligations under the DPA and has received a Notice of Dismissal of the
Complaint filed against it in this matter in the United States District Court
for the District of New Jersey. Neither the DPA nor the Complaint alleged that
the Company's conduct adversely affected patient health or patient care.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in